Precision Medicine News and Research

RSS

New study may facilitate personalized therapy for depression, other neurological disorders

Depression is the leading cause of disability worldwide, striking as many as one in four women and one in eight men in their lifetime.

5 May 2020

Researchers discover new gene involved in regulating the body's cholesterol

Precision medicine has the potential to tailor treatments to a patient's unique genetic sequence. But achieving this precision -- or developing new drugs -- requires knowing which genes are involved in disease.

4 May 2020

Individuals with high risk of cancer and CVD cannot be identified based on family history

Certain genetic changes, termed "pathogenic variants," substantially increase risk for cardiovascular disease and cancer--the leading causes of death--but testing to identify individual carriers is not part of current clinical practice.

4 May 2020

AHA awards grants to 12 teams for fast-tracked heart and brain health research related to COVID-19

Less than a month after issuing a rapid response call for scientific research proposals for fast-tracked studies of the effects of COVID-19 on the body's cardiovascular and cerebrovascular systems, the American Heart Association has awarded $1.2 million in grants to teams at 12 institutions across the U.S. to begin this unprecedented work.

2 May 2020

ACCC's BiomarkerLIVE project facilitates integration of precision medicine into practice

As the science and knowledge around biomarkers and molecular profiling continues to expand, oncology providers are challenged with efficiently implementing molecular testing into their everyday practice.

30 Apr 2020

The Importance of Quality Control on Cannabis Related Products

In this interview, Joshua Crossney talks to News-Medical Life Sciences about the recent advancements in the Cannabis industry and why quality anslyis and quality control are more important now than ever for cannabis medicinal products.

From Pittcon 30 Apr 2020

Gustave Roussy and Biognosys Announce Partnership

The severe pneumonitis in patients infected by SARS-Cov-2 requires prolonged treatment in intensive care units with mechanical ventilation.

From Biognosys 28 Apr 2020

Caprion - HistoGeneX Expands its biomarker capabilities and deploys molecular COVID-19 testing services

Caprion - HistoGeneX announced today that the company is launching a molecular PCR testing service for identifying patients with COVID-19.

28 Apr 2020

Investigational drug may hold benefit for patients with lung and ovarian cancers

In a first-time disclosure of IPN60090, a small-molecule inhibitor of the metabolic enzyme glutaminase (GLS1), researchers from The University of Texas MD Anderson Cancer Center's Therapeutics Discovery division and Ipsen Biopharmaceuticals reported the preclinical discovery and early-stage clinical development of this novel drug. IPN60090, now under investigation in a Phase I trial, may hold benefit for certain patients with lung and ovarian cancers.

27 Apr 2020

Study: Effective integration of diverse scientific disciplines is vital to address scientific problems

Announcing a new article publication for BIO Integration journal. In this commentary article the authors Phei Er Saw and Shanping Jiang from Sun Yat-sen University, Guangzhou, People's Republic of China consider the significance of interdisciplinary integration in academic research and application.

23 Apr 2020

A new method to deliver therapeutic proteins inside the body

A new way to deliver therapeutic proteins inside the body uses an acoustically sensitive carrier to encapsulate the proteins and ultrasound to image and guide the package to the exact location required, according to Penn State researchers. Ultrasound then breaks the capsule, allowing the protein to enter the cell.

23 Apr 2020

Emergex partners with George Mason University for highly pathogenic RNA virus studies

Emergex Vaccines Holding Limited, a biotechnology company developing CD8+ priming set-point vaccines to prevent serious infectious diseases, today announced that it has entered into an agreement with the George Mason University, based in Virginia, in the United States.

22 Apr 2020

Making long-term research project a translational success

The Digital Health Accelerator (DHA) of the Berlin Institute of Health (BIH) is helping the scientists to make the long-term research project a translational success.

22 Apr 2020

Rare structural genetic variants could play a role in schizophrenia

Most research about the genetics of schizophrenia has sought to understand the role that genes play in the development and heritability of schizophrenia. Many discoveries have been made, but there have been many missing pieces.

17 Apr 2020

Genetic vulnerability linked to emotional, social and psychiatric problems in children

Emotional, social and psychiatric problems in children and adolescents have been linked to higher levels of genetic vulnerability for adult depression.

16 Apr 2020

Smart ring predicts onset of COVID-19 in healthcare workers

As entire countries remain in lockdown due to the sweep of the novel coronavirus across the globe, researchers have found a way to protect those who are perhaps most at risk: healthcare workers.

13 Apr 2020

FDA approves new Rutgers saliva test for coronavirus

The FDA has granted emergency use authorization to Rutgers' RUCDR Infinite Biologics and its collaborators for a new collection approach that utilizes saliva as the primary test biomaterial for the SARS-CoV-2 coronavirus, the first such approval granted by the federal agency.

13 Apr 2020

Using computer software to optimize treatment for diabetic kidney diseases

Diabetic kidney diseases are the main cause of kidney failure in industrialized countries. An international, EU-funded R&D project - which is being headed by the Medical University of Innsbruck, and involves collaboration with the Medical University of Vienna and international partners - is being implemented with the aim of using computer software to provide personalized predictions of the disease's progression and bring about improvements in individuals' responses to treatment.

9 Apr 2020

Researchers develop online resource to refine results from RNA sequencing

DNA sequencing is becoming a more commonplace method for detecting diseases and improving precision medicine.

8 Apr 2020

Mount Sinai launches web-based app to capture symptoms, spread of COVID-19 in New York City

A team of data scientists, physicians, and engineers across the Mount Sinai Health System has come together to launch STOP COVID NYC, a web-based app to capture the symptoms and spread of COVID-19 in New York City--currently the epicenter of the nation's largest outbreak.

6 Apr 2020